Press release
United States Lead Small Interfering RNA (siRNA) Therapeutics Market at 17.4% CAGR on Regulatory Approvals & RNA Innovation
Small Interfering RNA (siRNA) Therapeutics Market
As per DataM Intelligence research report "Small Interfering RNA (siRNA) Therapeutics Market reached US$ 2.55 billion in 2024 and is expected to reach US$ 12.38 billion by 2033, growing with a CAGR of 17.4% from 2025 to 2033." Rising research and development activities, regulatory approvals, demand for targeted therapies against chronic and rare diseases, and advancements in delivery technologies are fueling growth in the small interfering RNA (siRNA) therapeutics market.
Download your exclusive sample report today: (corporate email gets priority access):
https://www.datamintelligence.com/download-sample/small-interfering-rna-therapeutics-market?sindhuri
Japan: Recent Industry Developments
✅ In October 2025, GC Corporation announced pharmacological studies for RECQL1-siRNA, a novel siRNA targeting the helicase RECQL1, aiming to develop treatments for advanced peritoneal cancers.
✅ In 2025, Investments in biotech and genomic medicine grew, with partnerships between local firms and international players advancing siRNA research for metabolic and genetic disorders.
✅ In 2025, Government-supported RNA research initiatives in Japan accelerated siRNA pipeline development for oncology and rare diseases.
United States: Recent Industry Developments
✅ In March 2025, The U.S. FDA approved fitusiran (Qfitlia) by Alnylam Pharmaceuticals as the seventh siRNA therapy, marking the first for hemophilia A or B.
✅ In October 2025, CRISPR Therapeutics and Sirius Therapeutics expanded collaboration to co-develop SRSD107, a long-acting Factor XI siRNA for thromboembolic disorders.
✅ In September 2025, Novotech CRO reported strong momentum with over 150 industry-sponsored siRNA clinical trials from 2020-2024.
Small Interfering RNA (siRNA) Therapeutics Market: Drivers
The small interfering RNA (siRNA) therapeutics market is driven by rising R&D for novel therapies, increasing regulatory approvals, and demand for precise alternatives to traditional drugs for life-threatening chronic and rare diseases. Technological advancements in delivery methods like GalNAc conjugates and lipid nanoparticles improve efficacy and targeting. Expanding applications in oncology, genetic disorders, cardiovascular, and metabolic conditions, along with supportive investments and precision medicine trends, further accelerate market growth.
Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/small-interfering-rna-therapeutics-market?sindhuri
Small Interfering RNA (siRNA) Therapeutics Market: Major Players
Alnylam Pharmaceuticals, Inc., Novartis AG, Novo Nordisk A/S, Arbutus Biopharma, ADARx Pharmaceuticals, Arrowhead Pharmaceuticals, Inc., Amgen Inc.
Segment Covered in the Small Interfering RNA (siRNA) Therapeutics Market:
By Drug
Patisiran, Givosiran, Lumasiran, Inclisiran, Nedosiran, Vutrisiran, Others.
By Indication
Transthyretin Amyloidosis, Acute Hepatic Porphyria, Primary Hyperoxaluria Type 1, Primary Hyperlipidemia, Others.
By Route of Administration
Intravenous, Subcutaneous.
Regional Analysis
North America - Dominant Share
North America leads with 52.2% share in 2024, driven by biopharmaceutical innovations, all approved siRNA therapies available, high sales, advanced infrastructure, and strong R&D in the United States.
Asia Pacific - Fastest-Growing
Asia Pacific expands rapidly due to rising biotech investments, healthcare infrastructure growth, government funding for RNA research, and increasing prevalence of target diseases.
Europe - Significant Share
Europe grows with regulatory support for novel therapeutics and focus on rare genetic disorders.
South America - Gradual Growth
South America shows steady progress amid improving access to advanced treatments and rising disease awareness.
Middle East & Africa - Emerging Growth
Middle East & Africa rises with investments in biotechnology and growing demand for precision therapies.
Purchase this report before year-end and unlock an exclusive 30% discount:
https://www.datamintelligence.com/buy-now-page?report=small-interfering-rna-therapeutics-market?sindhuri
(Purchase 2 or more Reports and get 50% Discount)
Request for 2 Days FREE Trial Access:
https://www.datamintelligence.com/reports-subscription?sindhuri
✅ Competitive Landscape
✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Consumer Behavior & Demand Analysis
✅ Import-Export Data Monitoring
✅ Live Market & Pricing Trends
Have a look at our Subscription Dashboard:
https://www.youtube.com/watch?v=x5oEiqEqTWg
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release United States Lead Small Interfering RNA (siRNA) Therapeutics Market at 17.4% CAGR on Regulatory Approvals & RNA Innovation here
News-ID: 4340920 • Views: …
More Releases from DataM Intelligence 4Market Research LLP
Artificial Intelligence Market to Witness Strong Growth Through 2031 | Machine L …
The Artificial Intelligence Market is witnessing prominent growth during the forecast period 2024 to 2031.The market is gaining strong momentum as organizations across industries increasingly adopt AI to drive automation, enhance decision-making, personalize customer experiences, optimize operations, and achieve cost efficiencies. This growth is fueled by rapid advancements in machine learning, natural language processing, computer vision, and other AI-driven technologies.
Growth is driven by surging demand for personalization in e-commerce and…
Preventive Healthcare Technologies Market Outlook - Driven by Telemedicine | Eur …
Preventive Healthcare Technologies and Services Market Size and Forecast
DataM Intelligence has published a new research report on "Preventive Healthcare Technologies and Services Market Size 2025". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of Top Key Players and Drivers. The purpose of this report is to provide a telescopic view of the current market size by value and volume,…
Chemical Tankers Market to Witness Robust Growth Through 2031 | Petrochemicals, …
The Chemical Tankers Market is experiencing robust growth during the forecast period 2024 to 2031.The market is gaining strong momentum as global chemical production expands, particularly across emerging economies. Rising international trade in petrochemicals, vegetable oils, and specialty chemicals is increasing demand for specialized chemical tankers designed to transport bulk liquid cargo safely, efficiently, and in compliance with stringent regulatory standards.
Growth is driven by rapid expansion in the chemical industry…
Health Assessment & Technology Evaluation Market Size Analysis - Driven by digit …
Health Assessment and Technology Evaluation Market Size and Forecast
DataM Intelligence has published a new research report on "Health Assessment and Technology Evaluation Market Size 2025". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of Top Key Players and Drivers. The purpose of this report is to provide a telescopic view of the current market size by value and volume,…
More Releases for RNA
CD Formulation Launches Custom Circular RNA Synthesis Service to Accelerate RNA …
CD Formulation introduces a customizable circRNA synthesis service, delivering high-quality, stable circRNAs for therapeutics, vaccines, and gene research, supported by advanced design and QC processes.
CD Formulation, a leading provider of advanced small nucleic acid synthesis [https://www.formulationbio.com/nucleic-acid/custom-small-nucleic-acid-synthesis.html] solutions, is proud to announce the launch of its fully customizable circular RNA (circRNA) synthesis service. This new service addresses the growing need for stable, non-immunogenic RNA molecules for therapeutic development, vaccine research, and…
Self-Amplifying RNA Synthesis Market Gains Traction as Biotech Firms Embrace Sca …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the " Self-Amplifying RNA Synthesis Market- (By Product & Service (Products (Enzymes & Reagents, Premade saRNA, Others), Custom Synthesis Services), By Application (Therapeutics Development (Oncology, Infectious Diseases, Others), Biomedical Research), By End-User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2034."
According to the latest research by InsightAce Analytic,…
RNA Extraction and RNA Purification Market: Growth, Trends & Competitive Landsca …
The global RNA Extraction and RNA Purification Market is expected to grow at 6.3% CAGR from 2025 to 2032.
This Market Report is the result of extensive research and analysis conducted by our team of experienced market researchers through -
• 70% efforts of Primary Research
• 15% efforts of Secondary Research
• 15% efforts from the subscription to Paid database providing industry overview, macro and micro economics factors, and financials of private limited…
RNA Targeting Small Molecules Therapeutics Market: Exponential Growth with Risin …
Estimations Predict a CAGR of 29.8% by 2029 in Global RNA Targeting Small Molecules Therapeutics Market Boosted by Precision Medicine, RNA Biomarker Identification and RNA Genetic Manipulation
What Is The Projected Market Size of The Global RNA Targeting Small Molecules Therapeutics Market And Its Growth Rate?
• The market will grow from $6.1 billion in 2024 to $7.87 billion in 2025 at a compound annual growth rate (CAGR) of 28.9%.
• Expected exponential…
Global DNARNA Extraction Kit Market by Type (Cell-free DNA (cfDNA), Sequence-spe …
"DNARNA Extraction Kit Market" is segmented by Company, Region (country), By Type, Application, stakeholders and other participants. This report provides an analysis of revenue and forecast across Type and Application segments for 2023-2032.
The market for DNARNA Extraction Kits has been thoroughly researched via primary and secondary sources to produce this research study. Along with a competitive analysis of the market, segmented by application, type, and geographical trends, it offers a…
Cancer RNA Expression Market to Reap Excessive Revenues by 2028(By sequencing te …
Worldwide cancer is one of the leading cause of death and effective way of treating it still looks unaccomplished in most parts of the world. The factors which influence the successful treatment of cancer are different depending on the stage of diagnosis, treatment availability and availability of trained healthcare professionals coupled with high economic burden of the disease. The gene expression of cancerous cells varies by cancer type and may…
